Abstract:Purpose: To identify the most sensitive period for detecting significant circadian and ultra‐short‐term intraocular pressure (IOP) fluctuation associated with disease progression in primary angle closure glaucoma (PACG). Methods: PACG eyes, which had been followed up for over 2 years under the CUHK PACG Longitudinal (CUPAL) Study, were recruited. Eyes with or without functional or structural glaucomatous progression were classified into ‘progressive’ or ‘stable’ groups based on serial visual field (VF) and retinal nerve fibre layer (RNFL) thickness documentations, respectively. Circadian and ultra‐short‐term IOP fluctuations were recorded by Sensimed Triggerfish® sensors with 288 readings over 30 s, at 5‐min intervals, over a 24‐h period. The circadian IOP fluctuation was represented by smoothed sensor output signals using B‐spline smoothing transform and described by functional data analysis. In each of seven activity‐related 1‐h periods during the examining day, the mean value of the amplitude‐frequency profiles of the signal fluctuations in twelve 30‐s intervals, which represent the ultra‐short‐term IOP fluctuation, was calculated by semi‐variogram/semi‐variance. The signals were compared between ‘progressive’ and ‘stable’ groups by permutation tests on functional t‐statistics. Results: Among the 25 recruited PACG eyes, 16 eyes were classified as RNFL ‘progressive’ group (the mean rate of change in global RNFL thickness: −0.199 ± 0.128 μm/month). Statistically significant differences were found during the time periods from 22:00 to 23:00 and from 07: 00 to 08:00 in gradients that reflected by the first derivative of the IOP fluctuation curve, as well as from 23:00 to 24:00 and 08:00 to 09:00 in curvatures that reflected by the second derivative of the IOP fluctuation curve, between the VF progressive and the VF stable groups ( p < 0.05). Gradients differences were also found during the time periods from 24:00 to 01:00 and 02:00 to 03:00 between structural progressive and stable groups ( p < 0.05). Higher signal fluctuations, in terms of amplitude‐frequency, were found during the first 1‐h period of sleeping in the RNFL ‘progressive’ group, compared to the RNFL ‘stable’ group ( p = 0.028). Conclusions: Between RNFL ‘progressive’ and ‘stable’ PACG eyes, significant differences in circadian IOP fluctuation and ultra‐short‐term IOP fluctuation at the 1‐h period after falling asleep were identified. Large circadian IOP fluctuations may be associated with disease progression in PACG eyes. The first hour of sleeping may be the most sensitive period for detecting significant short‐term IOP fluctuation in PACG eyes.

Personalized drug treatment for glaucoma based on the peak value in 24 hours' intraocular pressure measurement

Study on Changes of Intraocular Pressure Within 24 Hours in Primary Open Angle Glaucoma and Normal Eyes

Clinical study of 24-hour intraocular pressure curve measurement strategy

Strategies for Monitoring 24-Hour Intraocular Pressure Curve:41 Cases of Prospective Clinical Study

Effect of high myopia on 24-hour intraocular pressure in patients with primary open-angle glaucoma.

[Distribution of Peak Intraocular Pressure in 24-Hour and Correlation Between Peak Nocturnal Intraocular Pressure with Diurnal Intraocular Pressure Level in Primary Open Angle Glaucoma Patients].

Comparison of IOP Curves over 24-Hour Periods in Normal Tension Glaucoma and Primary Open-Angle Glaucoma

Twenty-four-hour Pattern of Intra-Ocular Pressure in Untreated Patients with Primary Open-Angle Glaucoma.

[A New Analysis Method for 24-Hour Intraocular Pressure Data].

Association of 24-Hour Intraocular Pressure Fluctuation with Corneal Hysteresis and Axial Length in Untreated Chinese Primary Open-Angle Glaucoma Patients.

Short‐term intraocular pressure fluctuation in primary angle closure glaucoma

Comparing 24-hour IOP fluctuation slope curve between newly diagnosed ocular hypertension and primary open-angle glaucoma

Comparison of Latanoprost and Brimonidine in the Treatment of Open Angle Glaucoma

Comparison of Intraocular Pressure Reducing Effects of Three Prostaglandin Eyedrops in Open-Angle Glaucoma

Intraocular Pressure Lowering Efficacy and Safety of Travoprost 0.004% As A Replacement Therapy in Patients with Open Angle Glaucoma or Ocular Hypertension

Timolol,brinzolamide and Travoprost in Treatment of Primary Open-Angle Glaucoma and Ocular Hypertension

Mean Amplitude of Intraocular Pressure Excursions: a New Assessment Parameter for 24-H Pressure Fluctuations in Glaucoma Patients

Fixed-combination Treatments for Intraocular Hypertension in Chinese Patients – Focus on Bimatoprost-Timolol

Survival of medical treatment success in primary open-angle glaucoma and ocular hypertension

A 12-Week, Double-Masked, Parallel-Group Study of the Safety and Efficacy of Travoprost 0.004% Compared with Pilocarpine 1% in Chinese Patients with Primary Angle-Closure and Primary Angle-Closure Glaucoma

Intraocular pressure and diurnal fluctuation of open-angle glaucoma and ocular hypertension: a baseline report from the LiGHT China trial cohort